Hospital shares tumble up to 7% amid looming price-cap debate
Shares of listed hospital operators fell sharply on the BSE, with Max Healthcare down 7% and others losing up to 6%, as worries grow over possible caps on private-room rates.
On Wednesday, listed hospital stocks retreated sharply on the BSE, with Max Healthcare sliding 7% to around ₹915 and other major players such as Apollo Hospital Enterprises, Fortis Healthcare, Yatharth Hospital & Trauma Care Services and Aster DM Quality Care each losing between 5% and 6%. The decline comes amid speculation that the Supreme Court may impose caps on private-hospital room rents after questioning the disparity between price-to-retailer and maximum retail prices of essential drugs.
A parliamentary standing committee has also recommended that private-room rates be aligned with three-star hotel tariffs and that standard packages be introduced for common procedures. Analysts from ICICI Securities, ICRA and Crisil note that past caps on medical devices and cash-transaction limits have hurt revenues, and any new pricing controls could further squeeze profitability and raise compliance costs for hospital chains. The broader regulatory focus on affordability and transparency in healthcare heightens uncertainty for the sector’s growth outlook.
